SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Life Scienc - Quaterly Results

25 Jul 2024 Evaluate
The total revenue for the quarter ended June 2024 remained nearly unchanged at Rs. 5886.16 millions.Net profit declined -17.69% to Rs. 1114.83 millions from Rs. 1354.50 millions.Operating Profit reported a sharp decline to 1649.78 millions from 1950.12 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 5886.16 5784.50 1.76 5886.16 5784.50 1.76 22832.14 21612.20 5.64
Other Income 54.93 18.51 196.76 54.93 18.51 196.76 120.42 289.57 -58.41
PBIDT 1649.78 1950.12 -15.40 1649.78 1950.12 -15.40 6862.88 6712.50 2.24
Interest 3.53 3.96 -10.86 3.53 3.96 -10.86 15.46 5.47 182.63
PBDT 1646.25 1946.16 -15.41 1646.25 1946.16 -15.41 6847.42 6707.03 2.09
Depreciation 143.87 126.12 14.07 143.87 126.12 14.07 534.52 420.94 26.98
PBT 1502.38 1820.04 -17.45 1502.38 1820.04 -17.45 6312.90 6286.09 0.43
TAX 387.55 465.54 -16.75 387.55 465.54 -16.75 1604.02 1616.48 -0.77
Deferred Tax 12.38 29.55 -58.10 12.38 29.55 -58.10 81.88 110.37 -25.81
PAT 1114.83 1354.50 -17.69 1114.83 1354.50 -17.69 4708.88 4669.61 0.84
Equity 245.05 245.05 0.00 245.05 245.05 0.00 245.05 245.05 0.00
PBIDTM(%) 28.03 33.71 -16.86 28.03 33.71 -16.86 30.06 31.06 -3.22

Alivus Life Sciences Share Price

1066.65 -6.50 (-0.61%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×